Back to Journals » Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy » Volume 8

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy


Archive: Volume 8, 2015

Relationship between chronic complications, hypertension, and health-related quality of life in Portuguese patients with type 2 diabetes

Sepúlveda E, Poínhos R, Constante M, Pais-Ribeiro J, Freitas P, Carvalho D

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:535-542

Published Date: 30 October 2015

Bariatric surgery outcomes: a single-center study in the United Arab Emirates

Abusnana S, Abdi S, Tagure B, Elbagir M, Maleckas A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:461-471

Published Date: 18 September 2015

Causes and consequences of obesity: epigenetics or hypokinesis?

Graham MR, Baker JS, Davies B

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:455-460

Published Date: 16 September 2015

Evaluating the impact of type 2 diabetes mellitus on cardiovascular risk in persons with metabolic syndrome using the UKPDS risk engine

Ogedengbe OS, Ezeani IU, Chukwuonye II, Anyabolu EN, Ozor II, Eregie A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:437-445

Published Date: 15 September 2015

Evaluation of the relationship between the pelvic floor muscles and insulin resistance

Micussi MT, Freitas RP, Angelo PH, Soares EM, Lemos TM, Maranhão TM

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:409-413

Published Date: 28 August 2015

Kinin B1 and B2 receptor deficiency protects against obesity induced by a high-fat diet and improves glucose tolerance in mice

Morais RL, Silva ED, Sales VM, Filippelli-Silva R, Mori MA, Bader M, Pesquero JB

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:399-407

Published Date: 26 August 2015

A novel, long-acting glucagon-like peptide receptor-agonist: dulaglutide

Gurung T, Shyangdan DS, O’Hare JP, Waugh N

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:363-386

Published Date: 10 August 2015

Immunization of AGE-modified albumin inhibits diabetic nephropathy progression in diabetic mice

Mashitah MW, Azizah N, Samsu N, Indra MR, Bilal M, Yunisa MV, Arisanti AD

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:347-355

Published Date: 4 August 2015

Anti-atherosclerotic effects of sitagliptin in patients with type 2 diabetes mellitus

Omoto S, Taniura T, Nishizawa T, Tamaki T, Shouzu A,Nomura S

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:339-345

Published Date: 27 July 2015

Health-related quality of life in type 1 and type 2 diabetic patients in a Portuguese central public hospital

Sepúlveda E, Poínhos R, Constante M, Pais-Ribeiro J, Freitas P, Carvalho D

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:219-226

Published Date: 29 April 2015

Withdrawal of sulfonylureas from patients with type 2 diabetes receiving long-term sulfonylurea and insulin combination therapy results in deterioration of glycemic control: a randomized controlled trial

Srivanichakorn W, Sriwijitkamol A, Kongchoo A, Sriussadaporn S, Plengvidhya N, Lertwattanarak R, Vannasaeng S, Thongtang N

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:137-145

Published Date: 2 March 2015

Sotagliflozin improves glycemic control in nonobese diabetes-prone mice with type 1 diabetes

Powell DR, Doree D, Jeter-Jones S, Ding ZM, Zambrowicz B, Sands A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:121-127

Published Date: 26 February 2015

Effect of different exercise intensities on the pancreas of animals with metabolic syndrome

Amaral F, Lima NEA, Ornelas E, Simardi L, Fonseca FLA, Maifrino LBM

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:115-120

Published Date: 13 February 2015

Angiotensin receptor blocker telmisartan suppresses renal gluconeogenesis during starvation

Tojo A, Hatakeyama S, Kinugasa S, Nangaku M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:103-113

Published Date: 13 February 2015

Sexual dysfunction in diabetic women: prevalence and differences in type 1 and type 2 diabetes mellitus

Mazzilli R, Imbrogno N, Elia J, Delfino M, Bitterman O, Napoli A, Mazzilli F

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:97-101

Published Date: 11 February 2015

Glycosylated hemoglobin as a screening test for hyperglycemia in antipsychotic-treated patients: a follow-up study

Steylen PMJ, van der Heijden FMMA, Hoogendijk WJG, Verhoeven WMA

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:57-63

Published Date: 23 January 2015

Type 2 diabetes in Brazil: epidemiology and management

Almeida-Pititto B, Dias ML, Moraes ACF, Ferreira SRG, Franco DR, Eliaschewitz FG

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:17-28

Published Date: 5 January 2015

Salivary glucose concentration exhibits threshold kinetics in normal-weight, overweight, and obese children

Hartman ML, Goodson JM, Barake R, Alsmadi O, Al-Mutawa S, Ariga J, Soparkar P, Behbehani J, Behbehani K, Welty F

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:9-15

Published Date: 17 December 2014

Health outcomes in diabetics measured with Minnesota Community Measurement quality metrics

Takahashi PY, St Sauver JL, Finney Rutten LJ, Jacobson RM, Jacobson DJ, McGree ME, Ebbert JO

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:1-8

Published Date: 16 December 2014